Home » Topics » Disease categories and therapies » Infection

Infection
RSS

FDA advisory committee recommends approval of Rocephin for AOM

Nov. 24, 1997

Favorable results obtained in pediatric study of Neuprex

Nov. 24, 1997

Takeda reports novel carbapenems

Nov. 24, 1997

New triazole antifungals from Pfizer

Nov. 24, 1997

Floxin recommended for FDA approval

Nov. 21, 1997

AMBI cleared by FDA to commence nisin trials

Nov. 19, 1997

New antifungals from Pola

Nov. 19, 1997

Sankyo isolates A-76356, novel antibacterial agent

Nov. 19, 1997

MiKasome enters phase II for UTI

Nov. 18, 1997

Merck & Co. isolates novel antifungal agent with potent, broad-spectrum activity

Nov. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest
BioWorld
A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal
BioWorld
The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...